NCT01675297View on ClinicalTrials.gov

Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis

PHASE4CompletedINTERVENTIONAL

Enrollment

1,053

Participants

Timeline

Start Date

July 4, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

April 15, 2014

Conditions

Osteoporosis

Interventions

DRUG

Risedronate/Cholecalciferol combination

Risendronate/Cholecalciferol combination once a week

DRUG

Risedronate

Risedronate once a week

Trial Locations (1)

156-755

Chung-ang university hospital, Seoul

All Listed Sponsors

lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT01675297 - Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis | Biotech Hunter | Biotech Hunter